Photo Release: The Department of Disease Control (DDC), the Ministry of Public Health,

Food and Healthcare Press Releases Friday December 1, 2017 15:46
Bangkok--1 Dec--4D Communications

SOFFELL Enesis Group and Dr. Prawit Wairungruangkul (4th person from left), Managing Director of CP Consumer Products Co., Ltd., together with the company's executives gave Soffell mosquito repellents, value at 1,728,000 baht in total, to the Department of Disease Control, Ministry of Public Health. The products would be delivered to mobile health units to be given out to people in areas prone to dengue fever and Zika fever, both of which have mosquitos as vectors. Dr. Panumat Yannawetsakul (4th person from right), Deputy Director of the Department of Disease Control, received the gifts on behalf of the department. This preventive healthcare activity is one of the social activities that Soffell has been continuously doing.


Latest Press Release

Merck Signs Distribution Agreement with Avanti(R) Polar Lipids

Merck , a leading science and technology company, today announced that it has entered into an agreement with Avanti(R) Polar Lipids to be the exclusive multinational distributor of the USA-based company's research lipids portfolio outside of the United...

Xultophy(R) Significantly Reduces Blood Sugar Levels, Body Weight and Risk of Hypoglycaemia for People With Type 2 Diabetes in Real-World Setting

Newly published data from real-world European clinical practice has shown that Xultophy(R) (insulin degludec/liraglutide) significantly reduced blood sugar levels in people with type 2 diabetes after six months.[1] The study looked at people with type 2...

Tresiba(R) Reduces Hypoglycaemia Regardless of Blood Sugar Level

People with either type 1 or type 2 diabetes treated with Tresiba(R) had fewer episodes of low blood sugar (hypoglycaemia) compared with people on insulin glargine U100 regardless of whether they had achieved blood sugar targets.[1] These new post-hoc...

Ryzodeg(R) Significantly Reduces the Risk of Low Blood Sugar in People With Type 2 Diabetes who Fast During Ramadan

In people with type 2 diabetes who fast during Ramadan, Ryzodeg(R) (insulin degludec/insulin aspart) reduced the overall rate of low blood sugar (hypoglycaemia) including severe episodes by 62% and the rate of nocturnal hypoglycaemia by 74% versus...

Interim Results of First-Ever Global Survey Show People with Type 2 Diabetes Underestimate their Cardiovascular Risk

- Globally, cardiovascular disease (CVD) is the most common cause of death in people with type 2 diabetes[1] - 1 in 3 respondents considered themselves to be at low risk of CVD[2] - 1 in 6 respondents had never discussed type 2 diabetes and...

Related Topics